Editorial & Columns ‘Mediocre’ India outlook merits policy attention November 2, 2024 | Abdul Wasey | No Comments | More
Editorial & Columns American Politics at its Lowest : Voting for Presidency begins amidst the Echo of Racist Overtones October 28, 2024 | Gopal Misra | No Comments | More
Editorial & Columns FY24 Review: Intellectual Capital of Top Indian Pharmaceutical Companies October 28, 2024 | Dr. Anil Kumar Angrish | No Comments | More
Editorial & Columns India and China relations need a cautious reset October 26, 2024 | Abdul Wasey | No Comments | More
Editorial & Columns Yuan to Replace American Dollar : BRICS initiative May Pave the Way for the Chinese Currency October 24, 2024 | Gopal Misra | No Comments | More
Editorial & Columns Digital House Arrest a Menace October 23, 2024 | Satish Singh | No Comments | More
Editorial & Columns The Glittering Gold in India October 23, 2024 | Satish Singh | No Comments | More
Editorial & Columns Pay Gap in Indian Pharmaceutical Industry: Remuneration of Managerial Personnel vis-à-vis Employees October 23, 2024 | Dr. Anil Kumar Angrish | No Comments | More
Editorial & Columns Growth is fine, but address hunger first October 19, 2024 | Abdul Wasey | No Comments | More